Payment overview · 2025
General Payments
$37.31
2 reported records · 2 companies
Healthcare provider profile · identity verified
Aja Jackson Devose, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · PHILADELPHIA, PA · NPI 1174863054
Verified facts
What the public records show
CMS Open Payments records show Aja Jackson Devose, D.O. received $37.31 in general payments during 2025 across 2 reported records.
Exact Sciences Corporation accounted for 60.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $22.47 | 60.2% | 1 | 2025 |
| SHIELD THERAPEUTICS INC | Unresolved — no canonical attribution shown | $14.84 | 39.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $37.31 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $22.47 | 1 | 2025 |
Source payment records
|
|||||
| ACCRUFER Normalized: accrufer |
Drug | SHIELD THERAPEUTICS INC | $14.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 562 | 190 |
| Amlodipine Besylate | Amlodipine Besylate | 500 | 149 |
| Losartan Potassium | Losartan Potassium | 313 | 120 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 268 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 207 | 52 |
| Lisinopril | Lisinopril | 191 | 60 |
| Gabapentin | Gabapentin | 184 | 61 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 183 | 79 |
| Metformin Hcl | Metformin Hcl | 178 | 53 |
| Fluticasone Propionate | Fluticasone Propionate | 176 | 79 |
| Omeprazole | Omeprazole | 169 | 49 |
| Furosemide | Furosemide | 166 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 163 | 56 |
| Levothyroxine Sodium | Levothyroxine Sodium | 154 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 137 | 42 |
| Eliquis | Apixaban | 129 | 28 |
| Nifedipine Er | Nifedipine | 119 | 40 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 102 | 36 |
| Trazodone Hcl | Trazodone Hcl | 102 | 34 |
| Simvastatin | Simvastatin | 101 | 29 |
| Ozempic | Semaglutide | 99 | 24 |
| Chlorthalidone | Chlorthalidone | 83 | 28 |
| Ibuprofen | Ibuprofen | 79 | 29 |
| Jardiance | Empagliflozin | 75 | 28 |
| Carvedilol | Carvedilol | 74 | 26 |
| Famotidine | Famotidine | 74 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 72 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 72 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 68 | 17 |
| Metformin Hcl Er | Metformin Hcl | 67 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 60 | 13 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 57 | 11 |
| Tamsulosin Hcl | Tamsulosin Hcl | 55 | 19 |
| Tramadol Hcl | Tramadol Hcl | 54 | 16 |
| Valsartan | Valsartan | 53 | 16 |
| Alendronate Sodium | Alendronate Sodium | 51 | 16 |
| Donepezil Hcl | Donepezil Hcl | 49 | 14 |
| Allopurinol | Allopurinol | 48 | 14 |
| Montelukast Sodium | Montelukast Sodium | 48 | 20 |
| Potassium Chloride | Potassium Chloride | 48 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 25 |
| Naproxen | Naproxen | 47 | 17 |
| Azithromycin | Azithromycin | 45 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 44 | 16 |
| Glipizide Er | Glipizide | 43 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 14 |
| Sertraline Hcl | Sertraline Hcl | 43 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 42 | 15 |
| Meloxicam | Meloxicam | 37 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 34 | 14 |
| Rybelsus | Semaglutide | 34 | 12 |
| Valacyclovir | Valacyclovir Hcl | 34 | 13 |
| Alprazolam | Alprazolam | 33 | suppressed |
| Prednisone | Prednisone | 33 | 22 |
| Colchicine | Colchicine | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Methylprednisolone | Methylprednisolone | 30 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 29 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | 12 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 28 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 25 |
| Atenolol | Atenolol | 27 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 27 | suppressed |
| Latanoprost | Latanoprost | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 24 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 20 | suppressed |
| Loperamide | Loperamide Hcl | 20 | suppressed |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Levofloxacin | Levofloxacin | 19 | 16 |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Nystatin | Nystatin | 19 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Spironolactone | Spironolactone | 18 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Finasteride | Finasteride | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 11 |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Ezetimibe | Ezetimibe | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 15 |
| Glimepiride | Glimepiride | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Letrozole | Letrozole | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | 11 |
| Lacosamide | Lacosamide | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Misoprostol | Misoprostol | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Azathioprine | Azathioprine | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Abilify Maintena | Aripiprazole | 11 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $37.31 · 2 records | Exact Sciences Corporation | ACCRUFER, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error